Previous Meetings

※Photographing or reproducing slides, videos of presentations, and abstracts is strictly prohibited without prior permission from the presenter and/or the GBCC.
*Uploaded presentation materials and recording videos of presentation are under the copyright transfer agreement.

Day 1, Apr 28 (Thu)

Day 2, Apr 29 (Fri)

Day 3, Apr 30 (Sat)

11:10-12:10

Plenary Lecture 1
Venue:

Halla Hall

Current Indications of Radiation Therapy
Bruce Haffty (Rutgers Cancer Institute of New Jersey, U.S.A.)Slide View Video View Abstract

12:10-13:10

Luncheon Symposium 1
Venue:

Halla Hall

Optimized Endocrine Treatment Strategy in ER+ Post Meno ABC Management
Antonio Llombart Cussac (Medical Oncology Hospital Arnau de Vilanova in Valencia, Spain)Slide View Video View

13:30-14:30

Plenary Lecture 2
Venue:

Halla Hall

Precision Medicine Based on Genomics in Breast Cancer
Jorge Reis-Filho (Memorial Sloan Kettering Cancer Center, U.S.A.)Slide View Video View

14:40-15:50

Symposium 1:

DCIS – What’s New?
Venue:

Halla Hall

Molecular and Pathological Changes during Progression from in situ to Invasive Cancer
So Yeon Park (Seoul National Univ. College of Medicine, Seoul National Univ. Bundang Hospital, Korea)Slide View Video View Abstract
Personalized Treatment of DCIS
Jeong Eon Lee (Samsung Medical Center, Korea)Slide View Video View Abstract
No Surgery for DCIS?
Mehra Golshan (Dana Farber Cancer Institute, Brigham and Women’s Hospital, U.S.A.)Video View Abstract

Panel Discussion 1:

Circulating Tumor DNA - Myth or Reality?
Venue:

Lotus Hall

Clinical Utility of CtDNA in Breast Cancer
Jorge Reis-Filho (Memorial Sloan Kettering Cancer Center, U.S.A.)Slide View Video View
Clinical Implications of Circulating Tumor Cells of Breast Cancer Patients: Role of Epithelial-mesenchymal Plasticity
Seung Il Kim (Yonsei Univ. College of Medicine, Korea)Slide View Video View Abstract

Oral Presentation 1
Venue:

Weolla Room

DETERMINATION OF ANTI-CANCER MECHANISMS OF GOSSYPETIN AND LUTEOLIN IN COMBINATION WITH CHEMOTHERAPEUTIC CYCLOPHOSPHOAMIDE ON MCF-7 HUMAN BREAST CANCER CELL LINES
Elif Candan (Fatih Univ., Turkey)Slide View Abstract
DEVELOPMENT AND VALIDATION OF PERSONALIZED EX VIVO PLATFORM MIMICKING PATIENT HETEROGENEOUS TUMOR MICROENVIRONMENT TO ENABLE PERSONALIZED TREATMENT FOR BREAST CANCER
Govind Babu K (Kidwai, India)Slide View Abstract
HI-PLEX FOR HIGH THROUGHPUT MUTATION SCREENING OF BRCA1, BRCA2, TP53, AND PALB2 IN BREAST AND OVARIAN CANCER PATIENTS
Wei Xiong Wen (Cancer Research Malaysia, Malaysia)Slide View Abstract
DEAD-BOX RNA HELICASE DP103 AS A BIOMARKER FOR THERAPEUTIC RESPONSE TO DOCETAXEL
Alan Prem Kumar (National Univ. of Singapore, Singapore)Slide View Abstract
THE BASIC FACTS OF KOREAN BREAST CANCER IN 2013: RESULTS OF A NATIONWIDE SURVEY AND BREAST CANCER REGISTRY DATABASE
Sun Young Min (Kyung Hee Univ. School of Medicine, Korea)Slide View Abstract
IDENTIFICATION OF MOLECULES ASSOCIATED WITH TAMOXIFEN RESISTANCE THROUGH GENE EXPRESSION PROFILING OF TAMOXIFEN-RESISTANT BREAST CANCER CELLS
Sang Hyeok Woo (Korea Institute of Radiological & Medical Sciences, Korea)Slide View Abstract
INHERITED PREDISPOSITION FOR BREAST CANCER IN DIVERSE HEREDITARY CANCER SYNDROMES: STRATEGIES FOR SYNDROME SPECIFIC GENETIC TESTING AND RISK MANAGEMENT
Rajiv Sarin (Tata Memorial Centre, India)Slide View Abstract
EFFICACY AND SAFETY OF EVEROLIMUS AND EXEMESTANE IN PATIENTS WITH ADVANCED BREAST CANCER FROM ASIA AND AFRICA: ASIAN SUBSET RESULTS FROM THE PHASE 3B EVEREXES STUDY
Young-Hyuck Im (Samsung Medical Center, Korea)Slide View Abstract

16:00-17:10

Symposium 2:

Optimal Breast Irradiation for Breast Cancer
Venue:

Halla Hall

Current Perspectives on Radiation Therapy in Autologous and Prosthetic Breast Reconstruction
Won Park (Samsung Medical Center, Korea)Slide View Video View Abstract
Regional Nodal Management in Breast Cancer: From Z11 to AMAROS
Bruce Haffty (Rutgers Cancer Institute of New Jersey, U.S.A.)Slide View Video View Abstract
Tumor Bed Boost Integration during Whole Breast Radiotherapy: A Review of the Current Evidence
Sung-Ja Ahn (Chonnam National Univ. Medical School, Korea)Slide View Video View Abstract

Panel Discussion 2:

Biomarker Driven Clinical Trial Design in the Era of Precision Medicine in Breast Cancer
Venue:

Lotus Hall

A Molecular Portrait of Asian Breast Cancer: Multi-omics and Immune Profiling of a Prospective Breast Cancer Cohort Enriched in Young, Premenopausal Patients
Zhengyan Kan (Pfizer, Inc., U.S.A.)Slide View Video View Abstract
Innovative Clinical Trial in the Era of Genomics
Yeon Hee Park (Samsung Medical Center, Korea)Slide View Video View Abstract

Education Session 1:

Current and Future Role of Neoadjuvant Therapy for Breast Cancer
Venue:

Weolla Room

Surgical Issues in Patients with Breast Cancer Receiving Neoadjuvant Chemotherapy
Mehra Golshan (Dana Farber Cancer Institute, Brigham and Women’s Hospital, U.S.A.)Abstract
Neoadjuvant Therapy of Early Stage HER 2-positive Breast Cancer: Latest Evidence and Clinical Implications
In Hae Park (National Cancer Center, Korea)Slide View Abstract
Neoadjuvant Endocrine Therapy in Breast Cancer
Wonshik Han (Seoul National Univ. Hospital, Korea)Slide View Abstract

KEEP ME UPDATED

Sign up for GBCC Newsletter

Global Breast Cancer Conference Secretariat